Genetic Risk and Hereditary Cancers

Sessions may also consider multigene panels covering BRCA1, BRCA2, PALB2, CHEK2, ATM, and mismatch-repair genes, together with their varying levels of risk. Presentations will examine risk-prediction models, polygenic risk scores, and population-based testing in selected settings. Researchers will discuss cascade testing, family communication, and the growing role of genetic counsellors supported by telehealth. Attention will be given to variants of uncertain significance, periodic reanalysis, and clear reporting standards. Privacy, insurance discrimination, direct-to-consumer testing, and consent for data sharing will be addressed. Surveillance protocols, the timing of risk-reducing surgery, and chemoprevention in carriers will be reviewed with attention to quality of life. Cultural and religious perspectives on inherited risk will also be considered.

 

 

    Related Conference of Genetic Risk and Hereditary Cancers

    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 03-04, 2026

    10th Global Meeting on Oncology and Radiology

    Madrid, Spain
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands

    Genetic Risk and Hereditary Cancers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in